These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 9870714)
1. Hypoxic and hyperoxic effect on blood phosphodiesterase activity in young and old rats. Spoto G; Di Giulio C; Contento A; Di Stilio M Life Sci; 1998; 63(25):PL349-53. PubMed ID: 9870714 [TBL] [Abstract][Full Text] [Related]
2. cGMP phosphodiesterase activity in diabetic rats eyes in normoxic, hypoxic and hyperoxic conditions. Trentini P; Giordano A; Santoleri F; Di Nicola M; Bianchi G; Di Giulio C; Spoto G Int J Immunopathol Pharmacol; 2004; 17(3 Suppl):17-20. PubMed ID: 16857101 [TBL] [Abstract][Full Text] [Related]
3. cAMP phosphodiesterase activity in diabetic rats eyes in normoxic, hypoxic and hyperoxic conditions. Santoleri F; Di Nicola M; Bianchi G; Tondi A; Ceccarini A; Di Giulio C; Trentini P; Spoto G Int J Immunopathol Pharmacol; 2004; 17(3 Suppl):7-10. PubMed ID: 16857099 [TBL] [Abstract][Full Text] [Related]
4. Alteration of glutathione transferase subunits composition in the liver of young and aged rats submitted to hypoxic and hyperoxic conditions. Di Ilio C; Angelucci S; Bucciarelli T; Pennelli A; Petruzzelli R; Di Giulio C; Miranda M; Amicarelli F; Sacchetta P Biochim Biophys Acta; 1996 Jun; 1312(2):125-31. PubMed ID: 8672534 [TBL] [Abstract][Full Text] [Related]
5. High activity of cyclic 3',5'-nucleotide phosphodiesterase in sera of patient with phaeochromocytoma. Nakai A; Nagasaka A; Ohyama T; Aono T; Iwase K; Hasegawa H; Hayami S; Hidaka H; Tanaka T; Niinomi M Clin Endocrinol (Oxf); 1986 Apr; 24(4):409-14. PubMed ID: 3017609 [TBL] [Abstract][Full Text] [Related]
6. Age-dependent ultrastructural alterations and biochemical response of rat skeletal muscle after hypoxic or hyperoxic treatments. Amicarelli F; Ragnelli AM; Aimola P; Bonfigli A; Colafarina S; Di Ilio C; Miranda M Biochim Biophys Acta; 1999 Jan; 1453(1):105-14. PubMed ID: 9989250 [TBL] [Abstract][Full Text] [Related]
7. Activity of cyclic nucleotide phosphodiesterases in granulocytes of chronic myelogenous leukemia (CML). A preliminary report. Naskalski JW; Uciński WS Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(1):134-40. PubMed ID: 2581858 [TBL] [Abstract][Full Text] [Related]
8. Cyclic nucleotide phosphodiesterase activity and the platelet release reaction. Taylor PM; Heptinstall S Thromb Haemost; 1978 Apr; 39(2):550-1. PubMed ID: 27878 [No Abstract] [Full Text] [Related]
9. Evidence for the activity of five adenosine-3',5'-monophosphate-degrading phosphodiesterase isozymes in the adult rat neocortex. Sutor B; Mantell K; Bacher B Neurosci Lett; 1998 Aug; 252(1):57-60. PubMed ID: 9756358 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the cyclic nucleotide phosphodiesterase subtypes involved in the regulation of the L-type Ca2+ current in rat ventricular myocytes. Verde I; Vandecasteele G; Lezoualc'h F; Fischmeister R Br J Pharmacol; 1999 May; 127(1):65-74. PubMed ID: 10369457 [TBL] [Abstract][Full Text] [Related]
12. Platelets and vascular smooth muscle: abnormalities of phosphodiesterase, aggregation, and cell growth in experimental and human diabetes. Hamet P; Sugimoto H; Umeda F; Franks DJ Metabolism; 1983 Jul; 32(7 Suppl 1):124-30. PubMed ID: 6191179 [TBL] [Abstract][Full Text] [Related]
13. Activation of cyclic nucleotide phosphodiesterase from isolated human peripheral blood lymphocytes by mitogenic agents. Epstein PM; Mills JS; Hersh EM; Strada SJ; Thompson WJ Cancer Res; 1980 Feb; 40(2):379-86. PubMed ID: 6243252 [No Abstract] [Full Text] [Related]
14. Hydrolysis of guanosine and adenosine 3',5'-monophosphates by rat blood. Patterson WD; Hardman JG; Sutherland EW Biochim Biophys Acta; 1975 Mar; 384(1):159-67. PubMed ID: 165831 [TBL] [Abstract][Full Text] [Related]
15. Differential effects of various phosphodiesterase inhibitors, pyrimidine and purine compounds, and inorganic phosphates on cyclic CMP, cyclic AMP and cyclic GMP phosphodiesterases. Helfman DM; Kuo JF Biochem Pharmacol; 1982 Jan; 31(1):43-7. PubMed ID: 6277336 [TBL] [Abstract][Full Text] [Related]
16. Studies on plasma cyclic nucleotide, cyclic nucleotide phosphodiesterase, beta-thromboglobulin, and myoglobin response in patients with acute myocardial infarction. Kurokawa Y; Fukuda I; Mozai T Bull Osaka Med Sch; 1983 Oct; 29(2):85-97. PubMed ID: 6210124 [No Abstract] [Full Text] [Related]
17. The effect of diamide on cyclic AMP levels and cyclic nucleotide phosphodiesterase in human peripheral blood lymphocytes. Wedner HJ Biochim Biophys Acta; 1980 Apr; 628(4):407-18. PubMed ID: 6245710 [TBL] [Abstract][Full Text] [Related]
18. Ontogeny of cyclic AMP and cyclic GMP phosphodiesterase activities and of calmodulin levels in guinea pig ureter. Cho YH; Wheeler MA; Weiss RM J Urol; 1988 May; 139(5):1095-8. PubMed ID: 2834569 [TBL] [Abstract][Full Text] [Related]
19. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Eckly AE; Lugnier C Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194 [TBL] [Abstract][Full Text] [Related]
20. Cyclic 3':5'-adenosine monophosphate phosphodiesterase and cyclic 3':5'-guanosine monophosphate phosphodiesterase of normal granulocytes and granulocytes of chronic myelogenous leukaemia. Uciński WS; Naskalski JW Haematologia (Budap); 1986; 19(4):275-83. PubMed ID: 3028916 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]